Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing and treating vitreous opacity and preparation method thereof

A technology for vitreous opacity and composition, which is applied in the field of pharmaceutical compositions for preventing and treating vitreous opacity and the preparation thereof, and can solve the problems that ultrasonic waves cannot be used in fresh lesions.

Inactive Publication Date: 2017-05-10
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Modern medicine mostly uses corticosteroid hormones, hemostasis, anticoagulation, enzyme preparations, iodine preparations, calcium preparations, ultrasound, sodium iodide iontophoresis, laser and vitrectomy, etc., but ultrasound, laser and surgery cannot be used for fresh lesions Most patients, especially those with mild symptoms, are unwilling to accept surgical treatment, so it is necessary to find new and effective treatments

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing and treating vitreous opacity and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1: Pharmaceutical composition for preventing and treating vitreous opacity and its preparation method

[0035] The composition and weight parts of the raw material medicine of the pharmaceutical composition for preventing and treating vitreous opacity are: 87 g of jaundice, 62 g of asiaticoside, 1.1 g of asiaticoside, 51 g of fluttering grass, 33 g of incense sticks;

[0036] Preparation:

[0037] (1) According to the ratio of the raw materials, take the chili, asiaticoside, fluttering grass, and a column of incense, mix well, use 34.5% ethanol by weight as a solvent, and extract at 26 °C by warm soaking, and the extraction times For 37 times, the extraction time is 18 hours each time, and the amount of solvent for each time is 50 times the total weight of the crude drug, filtered to obtain medicinal residues A and extract A, the extract A recovered ethanol, concentrated to a relative density of 1.10, and filtered. After passing through the HPD500 macroporous a...

Embodiment 2

[0040] Example 2: Pharmaceutical composition for preventing and treating vitreous opacity and its preparation method

[0041] The composition and weight of the raw material of the pharmaceutical composition for preventing and treating vitreous opacity are as follows: 86 g of jaundice, 64 g of asiaticoside, 1 g of asiaticoside, 52 g of fluffy grass, 30 g of incense sticks;

[0042] Preparation:

[0043] (1) According to the ratio of the raw materials, take the chili, asiaticoside, fluttering grass, and a column of incense, mix well, use 34.5% ethanol by weight as a solvent, and extract at 26 °C by warm soaking, and the extraction times For 37 times, the extraction time is 18 hours each time, and the amount of solvent for each time is 50 times the total weight of the crude drug, filtered to obtain medicinal residues A and extract A, the extract A recovered ethanol, concentrated to a relative density of 1.10, and filtered. After passing through the HPD500 macroporous adsorption ...

Embodiment 3

[0046] Example 3: Pharmaceutical composition for preventing and treating vitreous opacity and its preparation method

[0047] The composition and weight parts of the raw material medicine of the pharmaceutical composition for preventing and treating vitreous opacity are: 88 g of jaundice, 60 g of asiaticoside, 1.2 g of asiaticoside, 50 g of fluttering grass, 36 g of incense sticks;

[0048] Preparation:

[0049] (1) According to the ratio of the raw materials, take the chili, asiaticoside, fluttering grass, and a column of incense, mix well, use 34.5% ethanol by weight as a solvent, and extract at 26 °C by warm soaking, and the extraction times For 37 times, the extraction time is 18 hours each time, and the amount of solvent for each time is 50 times the total weight of the crude drug, filtered to obtain medicinal residues A and extract A, the extract A recovered ethanol, concentrated to a relative density of 1.10, and filtered. After passing through the HPD500 macroporous a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for preventing and treating vitreous opacity and a preparation method thereof. The pharmaceutical composition disclosed by the invention is prepared by matching the following crude drugs: crake, oberonia iridifolia, asiaticoside, fimbristylis dichotoma and hedyotis capituligera can be prepared into various dosage forms according to conventional preparation processes. The pharmaceutical composition has an obvious curative effect in prevention and treatment for vitreous opacity.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a pharmaceutical composition for preventing and treating vitreous opacity and a preparation method thereof. Background technique [0002] Vitreous opacities is not the name of the disease but the most common phenomenon of the vitreous. A variety of eye diseases can cause vitreous opacity, the most common are senile degeneration, myopic changes, posterior vitreous detachment and physiological floaters, in addition to retinal detachment, uveitis, primary familial amyloidosis, flash vitreous Liquefaction and other clinical manifestations such as dark shadows in front of the eyes may also appear. The vitreous body is a transparent gel-like tissue, clear and bright, which can stabilize the performance of the vitreous gel and ensure that the vitreous body and its surrounding retina are buffered when the eyeball is rotated or shaken. And the field of v...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/898A61P27/02A61K35/57A61K31/7024
CPCA61K36/898A61K31/7024A61K35/57A61K36/74A61K36/89A61K2236/333A61K2236/39A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com